PPD Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

PPD, Inc. provides drug development services to the biopharmaceutical industry worldwide. The company operates through Clinical Development Services and Laboratory Services segments...

Stats
Today's Volume	1.87M
Average Volume	1.44M
Market Cap	0.00
EPS	$0.430 ( 2021-10-27 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.151 (0.32%)

Insider Trading

Date	Person	Action	Amount	type
2021-12-08	Carlyle Group Inc.	Sell	55 722 733	Common Stock
2021-12-08	H&f Corporate Investors Vii, Ltd.	Sell	157 138	Common Stock
2021-12-08	Johnston David Michael	Buy	33 228	Stock Options (Right to Buy)
2021-12-08	Johnston David Michael	Buy	25 522	Common Stock
2021-12-08	Johnston David Michael	Sell	151 747	Stock Options (Right to Buy)

INSIDER POWER
0.00
Last 98 transactions
Buy: 2 703 151 \| Sell: 89 993 839

Volume Correlation

Long: 0.17 (neutral)

Short: 0.34 (neutral)

Signal:(54.867) Neutral

PPD Inc Correlation

10 Most Positive Correlations
TLND	0.918
STAY	0.897
MDCA	0.895
LMRKO	0.883
LMRKP	0.883
ECHO	0.877
GAINM	0.876
CNBKA	0.874
AMTBB	0.868
DVCR	0.865

10 Most Negative Correlations
TLGT	-0.86
BOWXU	-0.838

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PPD Inc Correlation - Currency/Commodity

0.85
( strong )

0.88
( strong )

-0.56
( weak negative )

0.85
( strong )

-0.61
( weak negative )

PPD Inc Financials

Annual	2020
Revenue:	$4.68B
Gross Profit:	$1.80B (38.42 %)
EPS:	$0.350

FY	2020
Revenue:	$4.68B
Gross Profit:	$1.80B (38.42 %)
EPS:	$0.350

FY	2019
Revenue:	$4.03B
Gross Profit:	$1.62B (40.24 %)
EPS:	$0.161

FY	2018
Revenue:	$3.75B
Gross Profit:	$1.47B (39.32 %)
EPS:	$0.300

Financial Reports:

No articles found.

PPD Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

PPD Inc

PPD, Inc. provides drug development services to the biopharmaceutical industry worldwide. The company operates through Clinical Development Services and Laboratory Services segments. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri- and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company was founded in 1985 and is headquartered in Wilmington, North Carolina.